Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Digestive Neuroendocrine Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531291
What this trial is testing

Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation

Who this might be right for
ESCCBiliary Tract CancerGastric Cancer+1 more
RenJi Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT07371663
What this trial is testing

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Who this might be right for
Solid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more
Beijing Tide Pharmaceutical Co., Ltd 266
Early research (Phase 1)Looking for participantsNCT07244835
What this trial is testing

DEG6498 in Participants With Solid Tumors

Who this might be right for
Malignant Neoplasms
Degron Therapeutics Co. 100
Testing effectiveness (Phase 2)Study completedNCT01560260
What this trial is testing

Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

Who this might be right for
Carney ComplexChondrosarcomaGastrointestinal Stromal Tumor+1 more
National Cancer Institute (NCI) 20
Early research (Phase 1)Active Not RecruitingNCT04044859
What this trial is testing

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

Who this might be right for
Endometrial CancerEsophageal CancerEsophagogastric Junction (EGJ)+6 more
USWM CT, LLC 120
Not applicableStudy completedNCT07651020
What this trial is testing

The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

Who this might be right for
Pancreatic CancerBreast CancerLung Cancer+6 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Post-approval studies (Phase 4)WithdrawnNCT02000739
What this trial is testing

Genetically-informed Therapies for Patients With Metastatic Cancer

Who this might be right for
Metastatic Cancer
Dartmouth-Hitchcock Medical Center
Not applicableEnded earlyNCT03073473
What this trial is testing

Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers

Who this might be right for
Pancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more
Cota Inc. 40
Not applicableLooking for participantsNCT05403177
What this trial is testing

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Who this might be right for
Breast CancerColorectal CancerPancreas Cancer+9 more
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Looking for participantsNCT06055439
What this trial is testing

Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Who this might be right for
Neuroendocrine TumorsColorectal CancerGastric Cancer
Chimeric Therapeutics 135
Early research (Phase 1)Study completedNCT01548482
What this trial is testing

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmLung Carcinoid TumorRecurrent Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 21
Not applicableEnded earlyNCT03407040
What this trial is testing

Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

Who this might be right for
Gastrointestinal CancersBreast CancerPancreatic Cancer+2 more
National Cancer Institute (NCI) 98
Testing effectiveness (Phase 2)Study completedNCT02431676
What this trial is testing

Survivorship Promotion In Reducing IGF-1 Trial

Who this might be right for
Breast CancerProstate CancerLung Cancer+8 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Testing effectiveness (Phase 2)Study completedNCT01869725
What this trial is testing

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

Who this might be right for
Adult MedulloblastomaChildhood MedulloblastomaNeuroblastoma+2 more
Sue O'Dorisio 68
Not applicableActive Not RecruitingNCT03022188
What this trial is testing

Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma

Who this might be right for
Neuroendocrine Tumors
Société Française d'Endoscopie Digestive 100
Testing effectiveness (Phase 2)Study completedNCT02402062
What this trial is testing

Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

Who this might be right for
Neuroendocrine TumorsPancreatic Neoplasms
Grupo Espanol de Tumores Neuroendocrinos 17
Not applicableEnded earlyNCT01359410
What this trial is testing

Reinforced Staple Line on Leak Rate in Distal Pancreatectomy

Who this might be right for
Pancreatic Neoplasms
Washington University School of Medicine 112
Testing effectiveness (Phase 2)Ended earlyNCT03300843
What this trial is testing

Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer

Who this might be right for
MelanomaGastrointestinal CancerBreast Cancer+2 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Next Page